Back to top
more

WisdomTree U.S. SmallCap Quality Dividend Growth ETF: (DGRS)

(Delayed Data from NASDAQ) As of Mar 28, 2024 03:59 PM ET

$49.64 USD

49.64
15,550

+0.28 (0.57%)

Volume: 15,550

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

After-Market: $49.64 0.00 (0.00 %) 7:58 PM ET

ETF Quote Details

Previous Close 49.36
Open 49.48
Bid 44.99
Ask 54.55
Day Low-High 49.44-49.81
52wk Low-High 38.46-49.81
Volume 15,550
NAV (month end) 47.61
Premium (+)/Discount (-) (month end)+1.75

Zacks Premium Research for DGRS

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

Hold 3
ETF Risk

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

Med
ETF Research Report

ETF Expense Ratio

Expense Ratio 0.38%
Dividend (Yield) $1.08 (2.19%)
Issuer WISDOMTREE

Benchmark for DGRS

WISDOMTREE US SMALCAP QUAL DIV GRO INDEX

The WisdomTree U.S. SmallCap Quality Dividend Growth Index is a fundamentally weighted index that consists of the small-capitalization segment of dividend-paying stocks with growth characteristics.

Fund Summary for DGRS

WISDOMTREE US SMALLCP QUAL DIV GRWTH ETF

The WisdomTree U.S. SmallCap Quality Dividend Growth ETF seeks to track the investment results of dividend-paying small-cap companies with growth characteristics in the U.S. equity market.